Surgeon Type and Anastomotic Leaks in Ovarian Cancer

Alexandra C. Istl,Nerlyne Desravines,Ugwuji N. Maduekwe
DOI: https://doi.org/10.1001/jamasurg.2024.2929
2024-10-10
JAMA Surgery
Abstract:For patients with advanced ovarian cancer, cytoreductive surgery (CRS) and platinum-based chemotherapy are pillars of treatment. 1 Optimal completeness of cytoreduction, which may necessitate multivisceral resections, aims to achieve minimal residual disease and improve oncologic outcomes. 2 ,3
surgery
What problem does this paper attempt to address?